📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions. (2021)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.15326/jcopdf.2020.0158

PubMed Identifier: 33156982

Publication URI: http://europepmc.org/abstract/MED/33156982

Type: Journal Article/Review

Volume: 8

Parent Publication: Chronic obstructive pulmonary diseases (Miami, Fla.)

Issue: 1

ISSN: 2372-952X